COVID-19 Linked to Cardiovascular Disease, Mortality Risk
A study was conducted to determine short- and long-term risk for cardiovascular disease and mortality in patients with a medical history of COVID-19.
A study was conducted to determine short- and long-term risk for cardiovascular disease and mortality in patients with a medical history of COVID-19.
Researchers sought to assess the risks for cardiometabolic disease following COVID-19 infection.
Investigators sought to evaluate the association of comorbid PD and SUD with the probability of hospitalization among patients with COVID-19 in the emergency department.
Researchers assessed the characteristics and outcomes of patients having lung transplantation for COVID-19-related end-stage lung disease.
Recent data show that the product is unlikely to be active against currently circulating SARS-CoV-2 variants.
A Canadian population-based study examined the association between OSA and the risk for COVID-19 infection or serious COVID-19-related complications.
The MOVe-AHEAD study enrolled over 1500 participants 18 years of age and older who resided in the same household with someone who tested positive for SARS-CoV-2.
The Lucira COVID-19 & Flu Home test is a single-use, nucleic acid amplification test intended for individuals with signs and symptoms consistent with a respiratory tract infection.
Anne Meneghetti, MD, juxtaposes the portrayal of fungal infections in HBO’s The Last of Us with real-world concerns about rising rates of antimicrobial resistance.
Researchers evaluated the effectiveness and safety of COVID-19 vaccination during pregnancy.